Logo image of ALGEV.PA

GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

Europe - EPA:ALGEV - FR0000033888 - Common Stock

183 EUR
+1 (+0.55%)
Last: 10/13/2025, 7:00:00 PM
Fundamental Rating

4

Overall ALGEV gets a fundamental rating of 4 out of 10. We evaluated ALGEV against 103 industry peers in the Machinery industry. No worries on liquidiy or solvency for ALGEV as it has an excellent financial health rating, but there are worries on the profitability. ALGEV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALGEV had positive earnings in the past year.
ALGEV had a positive operating cash flow in the past year.
In the past 5 years ALGEV has always been profitable.
Of the past 5 years ALGEV 4 years had a positive operating cash flow.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of ALGEV (1.21%) is worse than 62.14% of its industry peers.
ALGEV's Return On Equity of 1.52% is on the low side compared to the rest of the industry. ALGEV is outperformed by 65.05% of its industry peers.
ALGEV has a worse Return On Invested Capital (0.76%) than 75.73% of its industry peers.
ALGEV had an Average Return On Invested Capital over the past 3 years of 3.04%. This is significantly below the industry average of 8.61%.
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROIC 0.76%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

ALGEV has a Profit Margin (2.38%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ALGEV has declined.
ALGEV's Operating Margin of 1.68% is on the low side compared to the rest of the industry. ALGEV is outperformed by 73.79% of its industry peers.
ALGEV's Operating Margin has declined in the last couple of years.
ALGEV's Gross Margin of 63.62% is amongst the best of the industry. ALGEV outperforms 88.35% of its industry peers.
ALGEV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALGEV is destroying value.
ALGEV has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALGEV has less shares outstanding
ALGEV has a worse debt/assets ratio than last year.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ALGEV has an Altman-Z score of 3.72. This indicates that ALGEV is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ALGEV (3.72) is better than 80.58% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that ALGEV is not too dependend on debt financing.
ALGEV has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. ALGEV outperforms 90.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.72
ROIC/WACC0.1
WACC7.84%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 5.18 indicates that ALGEV has no problem at all paying its short term obligations.
ALGEV's Current ratio of 5.18 is amongst the best of the industry. ALGEV outperforms 98.06% of its industry peers.
ALGEV has a Quick Ratio of 3.79. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ALGEV (3.79) is better than 98.06% of its industry peers.
Industry RankSector Rank
Current Ratio 5.18
Quick Ratio 3.79
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

The earnings per share for ALGEV have decreased strongly by -75.10% in the last year.
Measured over the past years, ALGEV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.19% on average per year.
ALGEV shows a decrease in Revenue. In the last year, the revenue decreased by -8.66%.
The Revenue has been growing slightly by 5.90% on average over the past years.
EPS 1Y (TTM)-75.1%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-126.43%
Revenue 1Y (TTM)-8.66%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%-8.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.88, the valuation of ALGEV can be described as expensive.
62.14% of the companies in the same industry are cheaper than ALGEV, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ALGEV to the average of the S&P500 Index (27.53), we can say ALGEV is valued expensively.
With a Price/Forward Earnings ratio of 13.52, ALGEV is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALGEV is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.04. ALGEV is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 41.88
Fwd PE 13.52
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

ALGEV's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.64
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)11.8
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

ALGEV has a Yearly Dividend Yield of 2.75%.
ALGEV's Dividend Yield is rather good when compared to the industry average which is at 2.44. ALGEV pays more dividend than 82.52% of the companies in the same industry.
ALGEV's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.75%

5.2 History

On average, the dividend of ALGEV grows each year by 21.15%, which is quite nice.
Dividend Growth(5Y)21.15%
Div Incr Years4
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

117.62% of the earnings are spent on dividend by ALGEV. This is not a sustainable payout ratio.
The dividend of ALGEV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP117.62%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

GEVELOT SA

EPA:ALGEV (10/13/2025, 7:00:00 PM)

183

+1 (+0.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)10-30 2025-10-30
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap137.25M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.75%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP117.62%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 41.88
Fwd PE 13.52
P/S 0.99
P/FCF N/A
P/OCF 31.77
P/B 0.63
P/tB 0.64
EV/EBITDA 13.64
EPS(TTM)4.37
EY2.39%
EPS(NY)13.53
Fwd EY7.4%
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)5.76
OCFY3.15%
SpS184.19
BVpS288.75
TBVpS284.6
PEG (NY)11.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROCE 1%
ROIC 0.76%
ROICexc 0.85%
ROICexgc 0.87%
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
FCFM N/A
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexcg growth 3Y-45.56%
ROICexcg growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.85
Cap/Depr 107.05%
Cap/Sales 5.14%
Interest Coverage 250
Cash Conversion 48.26%
Profit Quality N/A
Current Ratio 5.18
Quick Ratio 3.79
Altman-Z 3.72
F-Score6
WACC7.84%
ROIC/WACC0.1
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.1%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-126.43%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.66%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%-8.45%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-81.83%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-180.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.26%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%